A Phase 1b, Open-Label Study of Sorafenib With BIIB022 in Subjects With Advanced Hepatocellular Carcinoma
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007175/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a phase 1b, open-Label study of sorafenib with BIIB022 in subjects with advanced
hepatocellular carcinoma.
提供机构：
Vivli
创建时间：
2021-06-10
